Skip to main content

Events & Presentations

The 17th World Congress on Targeting Mitochondria 2026

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

October 21st to 23rd, Berlin

Read More »

2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF)

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

June 5th, 2026 - Royal Sonesta New Orleans

Read More »

2026 American Society of Gene Therapy Annual Meeting

David Spencer, PhD - Chief Scientific Officer, Phoenix SENOLYTIX, Inc.

May 11-15th, Boston

Read More »

SENOTHERAPEUTICS SUMMIT 2025

Presenter: Kevin Slawin, M.D., Founder and CEO, Phoenix SENOLYTIX

September 16 - 19, 2025, Rome, Italy

Read More »

American Society of Gene Therapy Annual Meeting

Keshav Karki PhD, Daniel L. Jasinski PhD, Kevin M Slawin MD, and David M Spencer PhD

May 13th, 2025 | New Orleans, LA

Improved ApoptiCIDe™ Safety Switch Provides a Novel, Controllable Therapeutic Platform for Regulated Klotho Anti-Aging Gene Therapy
Read More »